[{"indications": "Indications\u00a0reduction of intra-ocular pressure in ocular hypertension and open-angle\r\nglaucoma either as adjunct to beta-blockers or prostaglandin\r\nanalogues or used alone in patients unresponsive\r\nto beta-blockers or if beta-blockers contra-indicated", "name": "BRINZOLAMIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "11 Eye", "11.6 Treatment of glaucoma", "Carbonic anhydrase inhibitors and systemic drugs", "BRINZOLAMIDE"], "cautions": "Cautions\u00a0systemic absorption follows topical application; renal tubular immaturity or abnormality; interactions: Appendix 1 (brinzolamide)", "side-effects": "Side-effects\u00a0\n(From Carbonic anhydrase inhibitors and systemic drugs: British National Formulary)\nCarbonic anhydrase inhibitors and systemic drugs; also taste\r\ndisturbances, dry mouth, headache, ocular disturbances (including\r\ncorneal erosion, corneal oedema, photophobia, and reduced visual acuity); less commonly nausea, vomiting, diarrhoea, dyspepsia, oesophagitis,\r\nflatulence, oral hypoaesthesia and paraesthesia, chest pain, bradycardia,\r\npalpitation, dyspnoea, cough, upper respiratory tract congestion,\r\npharyngitis, depression, sleep disturbances, nervousness, malaise,\r\ndrowsiness, amnesia, dizziness, paraesthesia, sinusitis, decreased\r\nlibido, erectile dysfunction, renal pain, epistaxis, nasal dryness,\r\nthroat irritation, tinnitus, alopecia; also reported arrhythmia, tachycardia, hypertension, peripheral oedema, asthma,\r\ntremor, vertigo, rhinitis, dermatitis, erythema", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/202585.htm", "doses": ["Apply twice daily increased to max. 3 times daily if necessary"], "pregnancy": "Pregnancy\u00a0avoid\u2014toxicity in animal studies"}, {"indications": "Indications\u00a0reduction of intra-ocular pressure in ocular hypertension and open-angle\r\nglaucoma either as adjunct to beta-blockers or prostaglandin\r\nanalogues or used alone in patients unresponsive\r\nto beta-blockers or if beta-blockers contra-indicated", "name": "BRINZOLAMIDE With timolol", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "11 Eye", "11.6 Treatment of glaucoma", "Carbonic anhydrase inhibitors and systemic drugs", "BRINZOLAMIDE", "With timolol"], "cautions": "Cautions\u00a0systemic absorption follows topical application; renal tubular immaturity or abnormality; interactions: Appendix 1 (brinzolamide)", "side-effects": "Side-effects\u00a0\n(From Carbonic anhydrase inhibitors and systemic drugs: British National Formulary)\nCarbonic anhydrase inhibitors and systemic drugs; also taste\r\ndisturbances, dry mouth, headache, ocular disturbances (including\r\ncorneal erosion, corneal oedema, photophobia, and reduced visual acuity); less commonly nausea, vomiting, diarrhoea, dyspepsia, oesophagitis,\r\nflatulence, oral hypoaesthesia and paraesthesia, chest pain, bradycardia,\r\npalpitation, dyspnoea, cough, upper respiratory tract congestion,\r\npharyngitis, depression, sleep disturbances, nervousness, malaise,\r\ndrowsiness, amnesia, dizziness, paraesthesia, sinusitis, decreased\r\nlibido, erectile dysfunction, renal pain, epistaxis, nasal dryness,\r\nthroat irritation, tinnitus, alopecia; also reported arrhythmia, tachycardia, hypertension, peripheral oedema, asthma,\r\ntremor, vertigo, rhinitis, dermatitis, erythema", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/202584.htm", "doses": ["Apply twice daily increased to max. 3 times daily if necessary", "Name[Azarga\u00ae (Alcon)  ] Ophthalmic suspension (= eye drops),\r\nbrinzolamide 10\u00a0mg, timolol (as maleate) 5\u00a0mg/mL, net price 5\u00a0mL =\r\n\u00a311.05Excipients  include benzalkonium chloride, disodium edetateDose\u00a0for raised intra-ocular pressure in open-angle glaucoma\r\nor ocular hypertension when beta-blocker alone not adequate, adult over 18 years apply twice daily"], "pregnancy": "Pregnancy\u00a0avoid\u2014toxicity in animal studies"}]